Thyroid Gland Disorder Treatment Market Size, Share, Growth and Industry Report

<p>The global thyroid gland disorder treatment market size reached US$ 2.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.3 Billion by 2032, exhibiting a growth rate (CAGR) of 3.11% during 2024-2032. The rising prevalence of hyperthyroidism and hypothyroidism, increasing utilization of effective combination drug therapies, and the wide availability of undiagnosed patients of thyroid gland disorder represent some of the key factors driving the market.</p>

<table align="center" border="1" cellpadding="1" cellspacing="1" dir="ltr" style="width:100%">
<thead>
<tr>
<th scope="col" style="width:70%">
<div style="text-align:left"><strong>Report Attribute</strong></div>
</th>
<th scope="col">
<div>Key Statistics</div>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>
<div><strong>Base Year</strong></div>
</td>
<td>2023</td>
</tr>
<tr>
<td>
<div><strong>Forecast Years</strong></div>
</td>
<td>
<div>2024-2032</div>
</td>
</tr>
<tr>
<td>
<div><strong>Historical Years</strong></div>
</td>
<td>
<div>2018-2023</div>
</td>
</tr>
<tr>
<td><strong>Market&nbsp;Size in 2023</strong></td>
<td>US$ 2.5 Billion</td>
</tr>
<tr>
<td><strong>Market Forecast in 2032</strong></td>
<td>US$ 3.3 Billion&nbsp;</td>
</tr>
<tr>
<td><strong>Market&nbsp;Growth Rate&nbsp;2024-2032</strong></td>
<td>3.11%</td>
</tr>
</tbody>
</table>

<p>IMARC Group provides an analysis of the key trends in each segment of the global thyroid gland disorder treatment market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on drug type, diseases type, route of administration, and distribution channel.</p>

<p>全球甲状腺疾病治疗市场规模于2023年达到了25亿美元。展望未来，IMARC集团预计该市场规模将在2032年增至33亿美元，在2024-2032年期间展现出3.11%的复合年增长率。甲状腺功能亢进症和甲状腺功能减退症的发病率上升、有效联合药物疗法的应用增加以及甲状腺疾病未确诊患者的广泛存在，均为推动市场增长的关键因素。</p>

<table align="center" border="1" cellpadding="1" cellspacing="1" dir="ltr" style="width:100%">
<thead>
<tr>
<th scope="col" style="width:70%">
<div style="text-align:left"><strong>报告属性</strong></div>
</th>
<th scope="col">
<div>关键统计数据</div>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>
<div><strong>基准年份</strong></div>
</td>
<td>2023</td>
</tr>
<tr>
<td>
<div><strong>预测年份</strong></div>
</td>
<td>
<div>2024-2032</div>
</td>
</tr>
<tr>
<td>
<div><strong>历史年份</strong></div>
</td>
<td>
<div>2018-2023</div>
</td>
</tr>
<tr>
<td><strong>2023年市场规模</strong></td>
<td>25亿美元</td>
</tr>
<tr>
<td><strong>2032年市场规模预测</strong></td>
<td>33亿美元</td>
</tr>
<tr>
<td><strong>2024-2032年市场增长率</strong></td>
<td>3.11%</td>
</tr>
</tbody>
</table>

<p>IMARC集团对全球甲状腺疾病治疗市场的各个细分市场关键趋势进行了分析，并提供了2024-2032年全球、区域和国家层面的预测。本报告根据药物类型、疾病类型、给药途径和分销渠道对市场进行了分类。</p>